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Background: Based on the importance of left ventricular (LV) diastolic function in
stratiﬁcation of the cardiac prognosis in patients with systolic heart failure (SHF),
we attempted to identify the prognostic impact of Doppler echocardiographic exam-
inations and plasma B-type natriuretic peptide (BNP) concentration.
Methods: Of 73 patients admitted with decompensated SHF (ejection fraction <45%),
58 were included. Among these, 21 patients had ischemic heart disease and 27
non-ischemic dilated cardiomyopathy. In all patients, Doppler echocardiographic
examinations and measurements of the plasma B-type natriuretic peptide concen-
tration were simultaneously performed before discharge. Patients were followed up
for 36 months after discharge. Primary end point for the follow-up was readmission
for acute decompensated heart failure or cardiac death.
Results: During the mean follow-up period of 28± 12 months, 16 patients (27.6%)
were readmitted with decompensated heart failure. Based on the stepwise multi-
variate Cox regression analysis, mitral E/A ratio (chi-square = 6.5, relative risk = 1.7,
p = 0.01) and BNP (chi-square = 3.9, relative risk = 1.7, p = 0.04) were identiﬁed as
independent predictors of primary endpoints. Based on ROC analysis, the optimal
cutoff point of E/A was 1.05 (AUC= 0.836, p = 0.002) and that of plasma BNP concen-
tration was ≥254.5 pg/ml (AUC= 0.768, p = 0.002). In high-risk patients with E/A ≥1,
event-free survival rates were signiﬁcantly lower in patients with BNP <254.5 pg/ml
(p < 0.001).
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Conclusions: The complementary assessment of Doppler transmitral ﬂow and plasma
BNP concentration may be reliable in identifying the prognosis of patients with SHF.


















































































sample volume placed at the tip of the mitral valve
leaﬂets. From the TMF, peak velocity of early wave
(E), peak velocity of late wave at the atrial contrac-© 2008 Japanese Colleg
reserved.
ntroduction
atients with heart failure accompanied by left
entricular (LV) systolic dysfunction (SHF) have sig-
iﬁcantly variable clinical courses. In patients with
HF, whose level of LV ejection fraction (EF) is insuf-
cient to stratify the cardiac prognosis, LV diastolic
unction has been used for this purpose. In the clini-
al setting, Doppler transmitral ﬂow (TMF) has been
ommonly used as a surrogate measure in assess-
ng LV diastolic function [1]. Previous studies have
hown that LV diastolic ﬁlling patterns by TMF pro-
ide additional information for stratiﬁcation of the
rognosis in patients with decompensated heart
ailure [2—5]. In contrast, the plasma B-type natri-
retic peptide (BNP) concentration is a reliable
arker to diagnose both LV systolic dysfunction
nd congestive heart failure, as well as to stratify
he prognosis of patients with SHF [6—9] Previous
tudies have shown that LV diastolic function is a
ajor determinant of plasma BNP concentration
10—12]. Thus, TMF and BNP have similar character-
stics in assessment of the increasing of LV preload
nd prognosis in patients with SHF. Despite the
nterest in SHF management using Doppler echocar-
iography and plasma BNP concentration, clinical
hysicians may still be confused about the implica-
ions and meaning of the test results. With this in
ind, the aim of this study was to determine the
omplementary and incremental value of a combi-
ation of Doppler echocardiographic examinations
nd plasma BNP concentration in stratiﬁcation of




total of 73 patients (58 men, 15 women; mean
ge 57± 15 years) who were admitted for SHF
EF <45%) were enrolled in this study. In all
atients, Doppler echocardiographic examinations
nd measurements of the plasma BNP concen-
ration were simultaneously performed before
ischarge. Patients with non-sinus rhythm, mitral
tenosis, moderate to severe mitral regurgita-




mr poor technical quality of Doppler echocardio-
raphic images were excluded from this study. Of 73
atients, 15 were excluded: 6 with loss of follow-
p, 4 with atrial ﬁbrillation, 3 without adequate
chocardiographic images, 1 who had died of malig-
ant lymphoma, and 1 who had died in a trafﬁc
ccident; and 58 (44 men, 14 women; mean age
6± 14 years) were included in the study popula-
ion.
Among these, 21 patients had ischemic heart dis-
ase and 27 non-ischemic dilated cardiomyopathy.
atients were followed up for 36 months after dis-
harge. Primary end point for the follow-up was
eadmission for acute decompensated heart failure
r cardiac death. This study was approved by the
ocal research ethics committee, and the patients
ave written informed consent.
linical risk factors
ultiple clinical and laboratory risk factors were
etermined, including presence of hypertension
systolic blood pressure >140 mmHg, diastolic blood
ressure >90mmHg, or treatment with antihy-
ertensive agents); presence of hyperliplidemia
serum cholesterol >220mg/dl or treatment with
ntihyperlipidemic agents); presence of diabetes
ellitus (fasting glucose >125mg/dl, hemoglobin
1c >6.4%, or treatment with antidiabetics).
chocardiographic examination
ll patients were examined in the left lateral posi-
ion. Doppler and M-mode echocardiographic data
ere obtained with an echocardiographic system
SSA 390A, Toshiba Medical, Tokyo, Japan) equipped
ith a multifrequency transducer, at a sweep speed
f 100mm/s. Images were recorded on super-VHS
ideo and then exported to a computer workstation
UIWS-300A, Toshiba Medical) for ofﬂine analysis.
he pulsed Doppler TMF was recorded from the
pical long-axis view, with a pulsed-wave Dopplerion (A), the ratio of E to A (E/A), deceleration time
f the early wave (DT), and duration of the late
ave (Ad) were measured. A pulsed Doppler pul-













































echocardiographic examination. Pulmonary venous
ﬂow was obtained with the sample volume placed
5—10mm from the junction of the left atrium and
the right upper pulmonary vein. The duration of
the reversal wave during atrial contraction (PVAd)
was determined. Color Doppler propagation veloc-
ity (Vp) was measured by an aliasing velocity level
based on the E of the TMF [13]. TMF patterns
were classiﬁed into 4 types: normal pattern, 1.0
E/A < 2.0, 160 <DT < 240ms, and (PVAd-Ad)<0ms;
abnormal relaxation pattern, E/A <1.0; pseudonor-
mal pattern, 1.0 E/A <2.0, 160  DecT <200ms,
and (PVAd-Ad) ≥0ms; and restrictive ﬁlling pattern,
E/A ≥2.0 and DecT <160ms, and (PVAd-Ad) ≥0ms
[14]. The ratio of E to Vp (E/Vp) was measured as
an index for LV ﬁlling pressure [15]. All Doppler
echocardiographic variables were represented as
the mean values calculated for 3-consecutive car-
diac cycles. LV end-diastolic volume, LV end-systolic
volume, and LVEF were measured using a modiﬁed
Simpson’s method.
Measurements of plasma BNP concentration
Blood was drawn into tubes containing ethylene-
diaminetetraacetic acid (1mg/ml) and aprotinin
(500U/ml) from a peripheral vein for BNP measure-
ments during the echocardiographic study. These
blood samples were chilled with ice and immedi-
ately centrifuged at 3000 rpm for 10min at 4 ◦C,
then stored at −80 ◦C until analysis. Plasma BNP
concentration was measured by immunoradiomet-
ric assay (Shionogi & Co. Ltd., Osaka, Japan), with
reference values of less than 20 pg/ml.
Statistical analysis
Data are expressed as the mean value± S.D.
Student’s unpaired t test was performed to com-
pare continuous values, and chi-square test for
categorical variables between the two groups. Log-
transformed values for BNP (log BNP) were used in
these analyses to reduce the effects of skewed dis-
tribution of BNP values. Correlations with log BNP
were evaluated by simple linear regression analysis.
A stepwise multilinear regression on the estimation
of log BNP was then performed. Receiver operat-
ing characteristic (ROC) curves were constructed
to determine optimal sensitivity and speciﬁcity.
Cardiac event-free survival curves were estimated
using the Kaplan-Meier method, and survival curves
were compared by log-rank test. Univariate Cox
proportional hazards analysis was used to adjust for
time-to-event. A multivariate Cox proportional haz-
ards model with a stepwise selection procedure was
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igniﬁcant predictors of primary endpoints. p < 0.05
as considered to indicate statistical signiﬁcance.
r. SPSS II for Windows statistical program (SPSS
nc., Chicago, IL, USA) was used for ROC curve anal-
sis. Remaining analyses were performed using Stat
iew software (J-5.0, Abacus, Berkeley, CA, USA).
esults
ll non-readmitted patients were followed up to 36
onths after discharge. During the mean follow-
p period of 28± 12 months, 16 patients (27.6%)
ere readmitted with acute decompensated heart
ailure and 6 (10.3%) suffered cardiac death dur-
ng their re-hospitalization. Comparisons of clinical
haracteristics between patients with and with-
ut re-hospitalization are summarized in Table 1.
iuretics were more prevalent in re-hospitalized
atients, but other characteristics did not dif-
er between groups. Doppler echocardiographic
ata are summarized in Table 2. In readmitted
atients, E was higher, A was lower, thereby mak-
ng E/A higher, and DT was shorter as compared
ith those in non-readmitted patients. In addition,
VAd, (PVAd-Ad), and E/Vp in readmitted patients
ere higher than those in non-readmitted patients.
TMF patterns were classiﬁed into abnor-
al relaxation pattern in 27 patients (46.6%),
seudonormal pattern in 19 (32.8%), and restric-
ive ﬁlling pattern in 12 (20.7%). Of the patients, 2
7.4%) with abnormal relaxation pattern, 6 (31.5%)
ith pseudonormal pattern, and 8 (66.7%) with
estrictive ﬁlling pattern were readmitted.
Fig. 1 shows that event-free survival rates were
igniﬁcantly lower in patients with pseudonormal
p = 0.02) or restrictive ﬁlling pattern (p < 0.001),
han in those with abnormal relaxation pattern.
owever, event-free survival rates did not differ
etween patients with pseudonormal pattern and
hose with restrictive ﬁlling pattern (p = 0.09).
In addition, based on ROC analysis, E/A ≥1.05
AUC= 0.836, p = 0.002) was identiﬁed as the opti-
al cutoff point to predict the primary end point.
Plasma BNP concentrations were signiﬁcantly
igher in readmitted patients, compared with those
ho were not readmitted (316± 268 pg/ml vs.
42± 225 pg/ml, p = 0.01). Plasma BNP concentra-
ions (log BNP) were signiﬁcantly correlated with
oppler echocardiographic variables (Table 3). In a
tepwise multiple linear regression analysis, E/Vp
nd (PVAd-Ad) were identiﬁed as the best vari-
bles in estimating log BNP level (r = 0.49, p < 0.001,
eta coefﬁcient E/Vp = 0.27, PVAd-Ad = 0.35). Based
n ROC analysis, plasma BNP concentration
254.5 pg/ml (AUC= 0.768, p = 0.002) was identi-
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Table 1 Comparison of clinical characteristics between patients with and without re-hospitalization
Re-hospitalization p-Value
(−), n = 42 (+), n = 16 (−) vs. (+)
Age, years 55± 15 56± 15 NS
Male 34 (81) 10 (63) NS
Ischemic heart disease 17 (40) 4 (25) NS
SBP, mmHg 113± 20 111± 16 NS
HR, bpm 73± 12 68± 13 NS
Hypertension 12 (29) 4 (25) NS
Diabetes mellitus 11 (26) 2 (13) NS
Hyperlipidemia 16 (38) 4 (25) NS
Medical therapy
Diuretics 21 (50) 13 (81) 0.01
ACE-I 25 (60) 8 (50) NS
ARB 11 (26) 4 (25) NS
-blockers 30 (71) 9 (56) NS
Calcium antagonists 8 (19) 2 (13) NS

















gValues are n (%) or mean± S.D. +, re-hospitalized; −, not re
angiotensin-converting enzyme inhibitor; ARB, angiotensin II r
ed as the optimal cutoff point to predict the
rimary end point. Event-free survival rates were
igniﬁcantly lower in patients with plasma BNP con-
entration ≥254.5 pg/ml as compared to those with
lasma BNP concentration < 254.5 pg/ml (28.6% vs.
5.0%, p < 0.001).
Univariate predictors of the primary endpoint
s analyzed by Cox proportional hazards model
re summarized in Table 4. Based on the step-





Table 2 Comparison of Doppler echocardiographic variable
Re-hospitalization
(−), n = 42
LVEDV, ml 203 ± 91
LVESV, ml 149 ± 77
EF, % 29.1 ± 8.1
LAD, mm 39.5 ± 4.7
E, cm/s 64.2 ± 22.7
A, cm/s 67.0 ± 22.8
E/A 1.1 ± 0.6
DT, ms 202 ± 75
Ad, ms 131 ± 23
PVAd, ms 143 ± 26
(PVAd-Ad), ms 11.5 ± 18.9
Vp, cm/s 31.2 ± 7.3
E/Vp 2.1 ± 0.7
Values are means± S.D. +, re-hospitalized; −, not re-hospitalized;
tricular end-systolic volume; EF, ejection fraction; E/A, ratio of pea
atrial dimension; DT, deceleration time of early transmitral ﬂow; A
reversal wave during atrial contraction of pulmonary venous ﬂow;
velocity.italized; SBP, systolic blood pressure; HR, heart rate; ACE-I,
or blocker.
RR] = 1.66, p = 0.01) as correlated with plasma BNP
oncentration (chi-square = 3.9, RR = 1.70, p = 0.04)
as identiﬁed as an independent predictor among
igniﬁcant predictors of primary endpoints. In addi-
ion, patients with E/A ≥1 were classiﬁed into 2
roups based on the plasma BNP concentration:
roup I, BNP < 254.5 ng/l (19 patients); Group II,
NP ≥254.5 (12 patients). Fig. 2 shows that event-
ree survival rates were signiﬁcantly lower in Group
I (p < 0.001).
s between patients with and without re-hospitalization
p-Value
(+), n = 16 (−) vs. (+)
210 ± 71 NS
157 ± 60 NS
25.7 ± 6.1 NS
41.3 ± 4.8 NS
81.0 ± 21.9 0.01
49.2 ± 23.1 0.01
2.1 ± 1.1 <0.001
152 ± 41 0.01
131 ± 28 NS
160 ± 29 0.03
30.3 ± 25.4 0.02
32.2 ± 9.5 NS
2.6 ± 0.7 0.02
LVEDV, left ventricular end-diastolic volume; LVESV, left ven-
k velocities of early (E) to late (A) transmitral ﬂow; LAD, left
d, duration of late (A) transmitral ﬂow; PVAd, duration of the
(PVAd-Ad), difference between PVAd and Ad; Vp, propagation
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Figure 1 Event-free survival plots for primary end point according to predischarge transmitral ﬂow patterns.








E/A, ratio of peak velocities of early (E) to late (A) transmi-
tral ﬂow; DT, deceleration time of early transmitral ﬂow; Ad,
duration of late (A) transmitral ﬂow; PVAd, duration of the
Figure 2 In patients with the ratio transmitral peak







preversal wave during atrial contraction of pulmonary venous
ﬂow; (PVAd-Ad), difference between PVAd and Ad; Vp, prop-
agation velocity.
Discussion
We have shown that combined assessments based
on Doppler TMF and plasma BNP concentration at
predischarge may be useful in the risk stratiﬁca-
tion and follow-up of patients with SHF. A feature
of the present study is the relatively longer follow-
up period (36 months), as compared with those in
previous studies (6 months to 24 months), which
compared prognostic efﬁcacy between Doppler
echocardiography and plasma BNP concentration
[9,16,17]. This study suggests that the combined





Table 4 Univariate predictors of primary endpoints by Cox
Chi-square Hazard
E/A 11.62 1.91 (1.
DT 5.35 0.99 (0.
PVAd-Ad 6.01 1.02 (1.
E/Vp 8.32 2.34 (1.
log BNP 7.84 4.32 (1.
E/A, ratio of peak velocities of early (E) to late (A) transmitral ﬂow
of late (A) transmitral ﬂow; PVAd, duration of the reversal wave du
difference between PVAd and Ad; Vp, propagation velocity./A)1.0, event-free survival plots for primary end point
ccording to predischarge plasma B-type natriuretic pep-
ide (BNP) concentration (BNP ≥254.5 or <254.5 pg/ml).
ogate in identifying the long-term prognosis under
egular clinical and optimal managements.
oppler-derived indexes and CHF
rognosisn the present study, the E/A ratio was identi-
ed as an independent predictor for the prognosis
ased on cardiac events. Previous studies have
hown a relationship between the restrictive ﬁll-
proportional hazards model






; DT, deceleration time of early transmitral ﬂow; Ad, duration





































































































Brognosis of heart failure
ng pattern characterized by higher E/A ratio and
hort DT and poor mortality prognosis in patients
ith heart failure [2—5]. The present study has
dditionally shown that the pseudonormal pattern
ay provide similar information about the prog-
osis of patients with SHF, and the approximate
ptimal level of the E/A ratio to stratify the end-
oint was close to 1.0. Whalley et al. [4] have
hown that patients with congestive heart failure
nd pseudonormal pattern had poor prognosis, sim-
lar to those with restrictive ﬁlling pattern, and
øller et al. [18] also have shown that patients
ith acute myocardial infarction and pseudonormal
attern had poor prognosis, also similar to those
ith restrictive ﬁlling pattern. In general, differen-
iation between normal pattern and pseudonormal
attern has been a clinical issue regarding the use
f TMF in identifying diastolic ﬁlling abnormalities
1]; however, on the basis that LV diastolic dysfunc-
ion is accompanied by systolic dysfunction, TMF
atterns progress from an abnormal relaxation pat-
ern to a pseudonormal pattern and then ﬁnally to a
estrictive ﬁlling pattern, depending on the preload
19]. Therefore, an increase of E/A ratio commonly
ndicates progression of diastolic dysfunction in
atients with SHF. In contrast, the present study has
hown that other Doppler indexes (DT, E/Vp, PVAd-
d) are also associated with the prognosis of our
atients, as previous studies have shown relation-
hips between these indexes and the prognosis in
atients with cardiac disease [3,18,20]. In patients
ith LV systolic dysfunction, the indexes derived
rom Doppler TMF are strongly correlated with LV
lling pressure [21,22]. As LV systolic dysfunction
as a basic criterion for selection of subjects in
his study, the E/A ratio may be identiﬁed as the
est predictive Doppler index. In previous studies,
he important independent predictors derived from
oppler echocardiography vary depending upon the
tudy cited, as follows: DT [3], E/Vp [18], (PVAd-Ad)
20], and the ratio of E to tissue Doppler early dias-
olic mitral annular velocity (E/E′) [16]. Inspection
eveals an index to estimate LV ﬁlling pressure is
n common to these indexes, and therefore reliably
etecting the presence of increased LV ﬁlling pres-
ure may provide additional information useful to
he stratiﬁcation of prognosis in patients with SHF.
he role of plasma BNP concentrationn comparison to the E/A ratio, we could not show
he superiority of plasma BNP concentration in the
rst step stratiﬁcation at predischarge. In previous
tudies comparing the prognostic efﬁcacy between






entration, the superiority has been controversial:
nly plasma BNP concentration was correlated with
he prognosis [9,17]; in contrast, Doppler index
E/E′) and plasma BNP concentration were incre-
entally correlated with prognosis in patients with
eart failure [16]. Plasma BNP concentration and
oppler TMF have similar determinants associated
ith LV diastolic properties [1,10—12,19]. In the
resent study, plasma BNP concentration was also
orrelated with diastolic Doppler indexes; how-
ver, plasma BNP concentrations are affected by
ther various factors: age, RV dysfunction, sever-
ty of mitral regurgitation, renal function, and
V hypertrophy, in addition to diastolic function
23,24]. The complex determinants of BNP may
xplain the weak correlations with LV ﬁlling pres-
ure in patients admitted to the intensive care unit
24,25], and may also explain the lack of speci-
city in detecting the prognosis of patients with
V systolic dysfunction in comparison to the E/A
atio. In contrast, the present study has shown
hat the plasma BNP concentration has a strong
redictive value for readmission in patients with
seudonormal or restrictive ﬁlling pattern. Logeart
t al. [26] showed that TMF patterns are more
ccurate in diagnosis of congestive heart failure
n patients with intermediate plasma BNP concen-
ration (80—300 pg/ml); in contrast, higher plasma
NP concentrations (>300 pg/ml) have similar accu-
acy to that of TMF patterns. As discussed above,
lasma BNP concentration determinants such as
enal dysfunction and mitral regurgitation may
omplicate the correlations between plasma BNP
oncentration and the diagnosis of heart failure.
n contrast, mitral regurgitation, RV overload, and
enal dysfunction have been independent features
f the mortality in patients with heart failure
27—29]. Therefore, plasma BNP concentration
elating such factors may have additional value to
tratify the risk of readmission in patients in the
etting of high risk based on the TMF.
linical implications
e suggest a clinical algorithm for stratiﬁcation
f patients with SHF (Fig. 3). As a ﬁrst step, the
/A ratio at predischarge should be used as a sur-
ogate measure in predicting prognosis of patients
ith SHF. In patients with E/A ratio ≥1.0, plasma
NP concentration ≥254 pg/ml is a strong pre-
ictive indicator for readmission, and may be an
ptimal target to determine the need for other
nterventions. In contrast, an E/A ratio <1.0 after
reatments is the strongest predictor of good out-
ome under optimal medication.
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[transmitral peak early diastolic velocity (E) to late dias-
tolic velocity (A; E/A) and plasma B-type natriuretic
peptide (BNP) concentration.
Study limitations
First, the study population might not have been
large enough to determine our suggestion. There-
fore, in the future, studies comprising larger num-
bers of patients are needed. However, in spite of
the relatively small number of patients, the optimal
cutoff value of plasma BNP concentration in pre-
dicting cardiac events as found (about 250 pg/ml)
was close to those in previous studies with larger
numbers of subjects [17,18]. Second, since patients
with atrial ﬁbrillation or severe valvular disease
were excluded, the results of our study should not
be extrapolated to such populations.
Conclusions
In patients with SHF, the E/A ratio may be the ﬁrst
measure to use as a predicator for the prognosis. In
patients with higher E/A ratio (≥1.0), plasma BNP
concentration may provide the incremental infor-
mation to stratify the risk of readmission as the
second measure. Thus, the complementary assess-
ment of Doppler TMF and plasma BNP concentration
may be reliable in identifying the prognosis of
patients with SHF, and determining the optimal tar-
get for treatments.References
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